COMPANY INFO
Colossal Biosciences, Inc. is an American biotechnology and genetic engineering company founded in 2021 by Harvard geneticist George Church and serial entrepreneur Ben Lamm. The company, headquartered in Dallas, Texas, has around 170 employees and operates in the biotechnology industry with a focus on using CRISPR technology for de-extinction and conservation of extinct and endangered species. Their mission is to restore lost species such as the woolly mammoth, Tasmanian tiger, and dodo bird to their natural habitats, advancing both biodiversity and ecosystem health through innovative genetic engineering. The official website is colossal.com.
Colossal Biosciences Inc. is an American biotechnology and genetic engineering company focused on de-extinction, conservation, and ecosystem restoration using cutting-edge CRISPR technology. Founded in 2021 by Harvard geneticist George Church and entrepreneur Ben Lamm, the company is pioneering efforts to revive species such as the woolly mammoth, Tasmanian tiger, and dodo bird.
The Colossal Biosciences Inc. leadership team blends expertise in biotechnology, science, digital strategy, finance, and business operations. The company’s executives possess deep academic credentials, notable entrepreneurial acumen, and extensive industry experience, driving innovation in genomic engineering and conservation initiatives. Their combined vision and dedication propel the company’s mission to the forefront of biotech advancement and species restoration.
Ben Lamm is the Founder and CEO of Colossal Biosciences, leading breakthrough bioscience and genetic engineering initiatives that target species de-extinction, biodiversity enhancement, and ecosystem repopulation. Ben Lamm has driven ambitious CRISPR-based projects, starting with the woolly mammoth, and assembled a world-class scientific advisory board and executive management team, cementing Colossal Biosciences Inc.’s reputation for innovation and growth.
Ben is a serial entrepreneur with five successful exits, including sales to industry giants Accenture, Zynga, and LivePerson. He holds a BBA from Baylor University and has previously co-founded companies such as Hypergiant Industries and Chaotic Moon. His background in startups, emerging tech, defense, and climate change gives him unique insight into scaling groundbreaking ventures, attracting top talent, and shaping the direction of Colossal Biosciences Inc.'s CEO-led vision.
Adam Milne is COO of Colossal Biosciences, steering operational excellence and delivering strategic growth. Adam Milne has played a pivotal role in achieving Unicorn status, orchestrating funding rounds, launching spin-offs, and maintaining the company’s culture and global expansion, solidifying the effectiveness of Colossal Biosciences Inc.’s executives and management team.
Adam brings nearly three decades of biopharma and leadership experience, including senior roles at Pfizer and BioLabs. He studied at Connecticut College and currently serves on several boards, with a career spanning drug development, operational initiatives, and capital-efficient business scaling.
Sam Singer is the Chief Financial Officer at Colossal Biosciences, structuring a robust finance organization and implementing strong fiscal controls. Sam Singer leads budgeting, financial reporting, and series financing efforts, guaranteeing the company’s financial stability as part of Colossal Biosciences Inc.’s management team.
With more than 20 years of financial and investment experience, Sam served as CFO at Totus Medicines and Vice President at Granahan Investment Management. He holds both a Bachelor of Science and a Master’s in Finance from Bentley University, bringing expertise in biotech financial planning, capital raising, and investment analysis.
Brian Beard is the Co-Founder and Chief Global Strategy and Legal Officer of Colossal Biosciences, guiding high-level strategy, governance, and major transactions. Brian Beard’s expertise in legal compliance, mergers, acquisitions, and corporate governance is vital to Colossal Biosciences Inc.'s leadership and expansion.
Brian holds a JD from the University of Iowa College of Law and has held prestigious roles at Wilson Sonsini and Gunderson Dettmer, specializing in corporate, venture, and private equity law. His broad legal background supports the company’s complex global initiatives.
Beth Shapiro is the Chief Science Officer at Colossal Biosciences Inc., spearheading research in de-extinction and conservation genomics. Beth Shapiro oversees scientific strategy, driving cutting-edge projects and ensuring the management team maintains a rigorous, research-driven approach.
Beth is a renowned professor at UC Santa Cruz, a Howard Hughes Medical Institute investigator, and holds a DPhil in Zoology from Oxford. With a deep academic portfolio including the book “How to Clone a Mammoth,” she brings unparalleled expertise in ecology, genomics, and ancient biomolecular research.
Matt James is the Chief Animal Officer, overseeing Colossal Biosciences’ animal operations, conservation efforts, and welfare protocols. Matt James creates and implements strategies to maintain the health, safety, and education surrounding animal operations, a cornerstone for realizing the company’s ambitious species restoration efforts.
Matt has over 15 years of experience in animal management, with previous work at Dallas Zoo and Zoo Miami. He earned an MBA in Strategic Marketing from the University of South Florida and a B.S. in Biology/Chemistry from Doane University, integrating scientific and operational best practices.
C.K. Sample III is VP of Data at Colossal Biosciences, leading data-driven initiatives and building intelligent software solutions to support the company’s innovation and scalability. C.K. Sample III delivers product vision and technological leadership that underpin Colossal Biosciences Inc.'s digital evolution.
Formerly CTO and product leader at Hypergiant, C.K. also co-founded Ceros and has held executive roles at YouEarnedIt and Chaotic Moon. He holds an M.Phil. from Fordham University and is known for integrating technology with product strategy.
James Kehler serves as VP of BioSynergy, helping translate scientific discoveries into biotechnology products at Colossal Biosciences Inc. James Kehler is integral for funding support, partnership development, and product translation, aligning company research with commercial impact.
James holds both a Ph.D. and VMD from the University of Pennsylvania, and founded One Health Scientific LLC. His background in translational research, veterinary science, and strategic alliances is a unique asset for Colossal Biosciences executives.
Joe Federer leads digital strategy and social marketing at Colossal Biosciences, developing brand and outreach frameworks that situate the company as an innovative leader in biotechnology. Joe Federer’s efforts grow public engagement and expand awareness of Colossal Biosciences Inc.'s leadership and scientific projects.
Joe has extensive experience in digital/social media strategy, with key roles at Reddit, BBDO, and Ketchum. He studied Public Relations at Loyola University Chicago and is a recognized author and speaker on digital ecosystems.
The Colossal Biosciences Inc. leadership team integrates world-renowned scientists, seasoned business operators, strategic thinkers, and technology visionaries. This diverse group anchors the company’s bold mission, steers innovation across multiple disciplines, and maintains the integrity of Colossal Biosciences’ management structure. With founders experienced in pioneering ventures and a team of executives committed to scientific and commercial excellence, Colossal Biosciences continues to advance de-extinction and conservation through exceptional leadership.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Colossal Biosciences Inc. leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.